|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/14 | (2006.01) |
| C07D 487/20 | (2006.01) | ||
| C07D 519/00 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2632467 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11838545.9 |
| Date of filing the European patent application | 2011-10-25 | |
| (97) | Date of publication of the European application | 2013-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-22 |
| (46) | Date of publication of the claims translation | 2016-09-12 |
| (86) | Number | PCT/US2011/057749 |
| Date | 2011-10-25 |
| (87) | Number | WO 2012/061156 |
| Date | 2012-05-10 |
| (30) | Number | Date | Country code |
| 406498 P | 2010-10-25 | US |
| (72) |
TAVARES, Francis, X., US
STRUM, Jay C., US
|
| (73) |
G1 Therapeutics, Inc.,
79 T.W. Alexander Drive 4401 Research Commons, Suite 105, Research Triangle Park, NC 27709,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | CDK inhibitoriai |
| CDK INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 15 | 289.00 EUR |
| 2026-10-25 |